Laboratory Corporation of America Holdings, Dba Labcorp v. Metabolite Laboratories, Inc.
This text of 543 U.S. 1185 (Laboratory Corporation of America Holdings, Dba Labcorp v. Metabolite Laboratories, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
C. A. Fed. Cir. The Acting Solicitor General is invited to file a brief in this case expressing the views of the United States limited to the following question:. “Respondent's patent claims a method for detecting a form of vitamin B deficiency, which focuses upon a correlation in the human body between elevated levels of certain amino acids and deficient levels of vitamin B. The method consists of the following: First, measure the level of the relevant amino acids using any device, whether the device is, or is not, patented; second, notice whether the amino acid level is elevated and, if so, conclude that a vitamin B deficiency exists. Is the patent invalid because one cannot patent ‘laws of nature, natural phenomena, and abstract ideas’? Diamond v. Diehr, 450 U. S. 175, 185 (1981).”
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
543 U.S. 1185, 125 S. Ct. 1413, 161 L. Ed. 2d 188, 73 U.S.L.W. 3512, 2005 U.S. LEXIS 2077, Counsel Stack Legal Research, https://law.counselstack.com/opinion/laboratory-corporation-of-america-holdings-dba-labcorp-v-metabolite-scotus-2005.